Hepatobiliary Neoplasia SIG: Obesity, Metabolic Syndrome and HCC

4 (1 vote)

Recorded On: 11/10/2019

Experts share new research in molecular hepatocarcinogenesis in the setting of NASH at this program, including global obesity trends, the association of metabolic syndrome and HCC, and HCC surveillance in patients with NASH/metabolic syndrome. They will present and compare evidence on HCC diagnosis and management specific to patients with obesity that may be applied to clinical practice.

Elisabetta Bugianesi
Hashem El-Serag
Jorge Marrero

Key:

Complete
Failed
Available
Locked
Epidemiology of Obesity, Diabetes and HCC World Wide
Open to view video.
Open to view video. Presenter: Hashem B. El-Serag
You must register to access.
Rationale for Surveillance in HCC for Patients with NASH/Metabolic Syndrome
Open to view video.
Open to view video. Presenter: Elisabetta Bugianesi
You must register to access.
Diagnosis and Management of HCC in Obesity
Open to view video.
Open to view video. Presenter: Jorge A. Marrero
You must register to access.
Final Evaluation
Final Evaluation
7 Questions
7 Questions Please complete the following evaluation form to share your feedback on this activity.
You must register to access.